Beyond Commodities: Building the Regenerative Route-to-Market for Biodiversity Ingredients.
Regeneration expands prosperity across four layers local economies, human health, living ecosystems, and institution.
It protects supply for future generations — and upgrades what people eat, drink, and put on their skin with high-integrity ingredients that support everyday well-being.
Ans it’s powered by two invisible engines: a cultural shift that reorients our values, and a technological layer that verifies our impact, but it only works if it functions as an economic cycle.
Right now, that cycle breaks in a very specific place: the route-to-market infrastructure that makes biodiversity ingredients buyable, verifiable, and scalable.
Here’s the uncomfortable math behind the story.
The global food system is structurally concentrated: ~75% of our food comes from 12 plants and 5 animals, and three crops (rice, maize, wheat) deliver ~60% of plant calories + protein.
Regeneration requires biodiversity revenue — but the market is optimized for a tiny ingredient set.
And in the amazon basin, the opportunity is massive: it’s estimated to host up to ~50,000 plant species, and researchers have cataloged 2,253 major non-timber forest products (ntfps) from trees and large palms — including 1,037 edible food sources and 1,001 plants with documented medicinal uses.
Yet the commercialization pattern is predictable: the evidence base itself is described as patchy and concentrated around a few high-commercial-value ntfps — a mirror of what happens when route-to-market rails are missing.
So the leverage point is clear: close the gap between regeneration and commercialization.
What actually has to scale for regeneration to scale
1. Middle infrastructure (the connective tissue)
processing, aggregation, transport, compliance, and market channels. This layer is capex-heavy, thin-margin, and typically requires patient, flexible capital.
2. R&d-to-market translation + verification (the credibility engine)
turning research and long-standing knowledge into ingredient specs and formulation briefs — plus the data/tech layer that makes it market-ready:
compositional testing, quality markers, contaminant screens, chain-of-custody traceability, claims boundaries, and substantiation packages.
Without verified data attached to ingredients, you don’t have durable differentiation.
No differentiation = no credibility premium.
No credibility premium = biodiversity gets treated like a raw input.
3. Demand pathways (the system nobody “owns”)
repeatable routes that make biodiversity investable and buyable — not as a one-off story, but as a scalable system.
What we’re building
Amaz is joining forces with all1 ventures and transitioning from a beverage brand into a bridge for bioeconomy ingredients — building demand pathways that let rainforest projects diversify beyond commodities.
At aterra studio, we support founders, supply chain operators, and cpg capital to do the same:
→ Go-to-market systems designed from the forest outward
→ Brand/positioning that centers origin integrity (not regen-wash)
→ R&D-to-market translation + verification (ingredient specs, testing plan, traceability, claims boundaries, substantiation pack, formulation briefs)
→ Capital + market design that funds infrastructure, not just marketing
If you’re a founder building something innovative in wellness, food, or beauty — and you believe the future lies in biodiversity and regenerative design — come talk to us.
If you’re deploying capital into the next generation of CPG — and want to back not just brands but systems — let’s connect.
If you’re part of the supply chain ecosystem (ingredient platforms, producer networks, aggregators, certifiers, traceability/data providers, co-manufacturing, logistics, distribution) and you want to be part of the map we’re building — let’s connect.
Sign up here to get the gtm blueprint we use to bring regenerative rainforest ingredients to market —
👉 https://www.aterrastudio.co/the-regenerative-gtm-roadmap
Sources:
1. World economic forum — global value chains “structural volatility” press release: https://www.weforum.org/press/2026/01/global-supply-chains-enter-era-of-structural-volatility-world-economic-forum-report-finds/
2. World economic forum — global value chains outlook 2026: https://www.weforum.org/publications/global-value-chains-outlook-2026-orchestrating-corporate-and-national-agility/
3. Unfccc — cop30 (belém, brazil): https://unfccc.int/cop30
4. Croatan institute — investing in regenerative agriculture infrastructure across value chains: https://croataninstitute.org/wp-content/uploads/2022/07/croatan-investing-in-regenerative-agriculture-infrastructure-across-value-chains_web.pdf
5. Rosenfeld et al. (2024) — ntfps systematic review (brazilian amazon): https://doi.org/10.1016/j.forpol.2024.103228
6. Clement et al. (2024) — amazon bioeconomy challenges / forest foods: https://doi.org/10.1016/j.tfp.2024.100583
7. Cardoso et al. (2017, pnas) — amazon basin plant diversity estimate: https://www.pnas.org/doi/10.1073/pnas.1706756114
8. Fao — agrobiodiversity concentration framing (12 plants/5 animals; 3 crops ~60%): https://www.fao.org/4/y5609e/y5609e02.htm
9. Ftc — health products compliance guidance (substantiation expectations): https://www.ftc.gov/system/files/ftc_gov/pdf/health-products-compliance-guidance.pdf
Fda — structure/function claims: https://www.fda.gov/food/nutrition-food-labeling-and-critical-foods/structurefunction-claims
